UK markets open in 7 hours 55 minutes

BioNTech SE (22UA.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
81.50-1.40 (-1.69%)
At close: 08:48PM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
3,819,000
3,819,000
17,310,600
18,976,700
482,300
Cost of revenue
599,800
599,800
2,995,000
2,911,500
59,300
Gross profit
3,219,200
3,219,200
14,315,600
16,065,200
423,000
Operating expenses
Research development
1,783,100
1,783,100
1,537,000
949,200
645,000
Selling general and administrative
557,700
557,700
541,200
327,200
108,500
Total operating expenses
2,315,000
2,315,000
2,011,800
1,138,100
505,400
Operating income or loss
904,200
904,200
12,303,800
14,927,100
-82,400
Interest expense
-
-
16,200
5,400
2,000
Total other income/expenses net
-67,800
-67,800
620,700
145,100
-59,900
Income before tax
1,186,100
1,186,100
12,954,100
15,046,400
-145,800
Income tax expense
255,800
255,800
3,519,700
4,753,900
-161,000
Income from continuing operations
930,300
930,300
9,434,400
10,292,500
15,200
Net income
930,300
930,300
9,434,400
10,292,500
15,200
Net income available to common shareholders
930,300
930,300
9,434,400
10,292,500
15,200
Basic EPS
11.27
3.87
38.78
42.18
0.06
Diluted EPS
11.27
3.83
37.77
39.63
0.06
Basic average shares
241,956
240,600
243,300
244,000
253,300
Diluted average shares
241,956
242,700
249,800
259,700
253,300